Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites

•Programmable nucleases are efficient tools for genome engineering and synthetic biology applications.•Genome editing can be applied to secondary metabolism engineering using forward and reverse genetics protocols.•Epigenome editing is a promising technology for discovery and production improvement...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biotechnology 2017-01, Vol.241, p.50-60
Main Authors: Leitão, Ana Lúcia, Costa, Marina C., Enguita, Francisco J.
Format: Article
Language:English
Subjects:
CRISPR-Cas Systems
CRISPR-Cas9
Epigenome editing
Gene Editing
Genome editing
Genomics
Hybrid metabolites
Metabolic Engineering
Secondary metabolism
TALEN
Transcription Activator-Like Effector Nucleases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Programmable nucleases are efficient tools for genome engineering and synthetic biology applications.•Genome editing can be applied to secondary metabolism engineering using forward and reverse genetics protocols.•Epigenome editing is a promising technology for discovery and production improvement of secondary metabolites. Genome engineering is a branch of modern biotechnology composed of a cohort of protocols designed to construct and modify a genotype with the main objective of giving rise to a desired phenotype. Conceptually, genome engineering is based on the so called genome editing technologies, a group of genetic techniques that allow either to delete or to insert genetic information in a particular genomic locus. Ten years ago, genome editing tools were limited to virus-driven integration and homologous DNA recombination. However, nowadays the uprising of programmable nucleases is rapidly changing this paradigm. There are two main families of modern tools for genome editing depending on the molecule that controls the specificity of the system and drives the editor machinery to its place of action. Enzymes such as Zn-finger and TALEN nucleases are protein-driven genome editors; while CRISPR system is a nucleic acid-guided editing system. Genome editing techniques are still not widely applied for the design of new compounds with pharmacological activity, but they are starting to be considered as promising tools for rational genome manipulation in biotechnology applications. In this review we will discuss the potential applications of programmable nucleases for the metabolic engineering of secondary metabolites with biological activity.
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2016.11.009